Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegilalide analgesic effect in hysteroscopic surgery under non-intubation anesthesia
ChiCTR2500104597Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegilalide in postoperative pain and perioperative pain (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Visual analog scale (VAS) pain scores and Incidence of adverse reactions. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
tegilalide
03
Conditions
postoperative painperioperative pain
Beyond the preview
Go deeper on ChiCTR2500104597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104597.